{"title":"人工智能预测肝硬化患者肝细胞癌风险。","authors":"Imen Akkari, Hanen Akkari, Raida Harbi","doi":"10.4251/wjgo.v17.i6.107414","DOIUrl":null,"url":null,"abstract":"<p><p>Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related deaths worldwide. The primary risk factor for HCC is cirrhosis. Identifying individuals who are at high risk of developing HCC will have numerous benefits for patient outcomes, patient quality of life, and the global healthcare system. Artificial intelligence (AI) has the capability to develop systems that emulate human intelligence. Recent studies have highlighted the potential of AI in the management of HCC, and the application of AI appears promising for identifying high-risk groups among patients with cirrhosis who require closer monitoring. Ultimately, the aim of AI in the field of HCC clinical care is to enable earlier diagnosis and consequently improve prognosis.</p>","PeriodicalId":23762,"journal":{"name":"World Journal of Gastrointestinal Oncology","volume":"17 6","pages":"107414"},"PeriodicalIF":2.5000,"publicationDate":"2025-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12179862/pdf/","citationCount":"0","resultStr":"{\"title\":\"Artificial intelligence to predict hepatocellular carcinoma risk in cirrhosis.\",\"authors\":\"Imen Akkari, Hanen Akkari, Raida Harbi\",\"doi\":\"10.4251/wjgo.v17.i6.107414\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related deaths worldwide. The primary risk factor for HCC is cirrhosis. Identifying individuals who are at high risk of developing HCC will have numerous benefits for patient outcomes, patient quality of life, and the global healthcare system. Artificial intelligence (AI) has the capability to develop systems that emulate human intelligence. Recent studies have highlighted the potential of AI in the management of HCC, and the application of AI appears promising for identifying high-risk groups among patients with cirrhosis who require closer monitoring. Ultimately, the aim of AI in the field of HCC clinical care is to enable earlier diagnosis and consequently improve prognosis.</p>\",\"PeriodicalId\":23762,\"journal\":{\"name\":\"World Journal of Gastrointestinal Oncology\",\"volume\":\"17 6\",\"pages\":\"107414\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2025-06-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12179862/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"World Journal of Gastrointestinal Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.4251/wjgo.v17.i6.107414\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Gastrointestinal Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4251/wjgo.v17.i6.107414","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
Artificial intelligence to predict hepatocellular carcinoma risk in cirrhosis.
Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related deaths worldwide. The primary risk factor for HCC is cirrhosis. Identifying individuals who are at high risk of developing HCC will have numerous benefits for patient outcomes, patient quality of life, and the global healthcare system. Artificial intelligence (AI) has the capability to develop systems that emulate human intelligence. Recent studies have highlighted the potential of AI in the management of HCC, and the application of AI appears promising for identifying high-risk groups among patients with cirrhosis who require closer monitoring. Ultimately, the aim of AI in the field of HCC clinical care is to enable earlier diagnosis and consequently improve prognosis.
期刊介绍：
The World Journal of Gastrointestinal Oncology (WJGO) is a leading academic journal devoted to reporting the latest, cutting-edge research progress and findings of basic research and clinical practice in the field of gastrointestinal oncology.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
